The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in

John McGonigle1, Anna Murphy2, Louise M Paterson1

  • 11 Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK.

Abstract

Related Concept Videos